documents: FDA-2023-N-0795-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-0795-0004 | FDA | FDA-2023-N-0795 | Reference 7 - Shengchao-s12874-017-0353-1 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising | Supporting & Related Material | Background Material | 2023-04-26T04:00:00Z | 2023 | 4 | 2023-04-26T19:38:32Z | 0 | 0 | 090000648598ca75 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref